PARUCH, Kamil, Michael DWYER, Carmen ALVAREZ, Courtney BROWN, Tin-Yau CHAN, Ronald DOLL, Kerry KEERTIKAR, Chad KNUTSON, Brian MCKITTRICK, Jocelyn RIVERA, Randall ROSSMAN, Greg TUCKER, Thierry FISCHMANN, Alan HRUZA, Vincent MADISON, Amin NOMEIR, Yaolin WANG, Emma LEES, David PARRY, Nicole SGAMBELLONE, Wolfgang SEGHEZZI, Lesley SCHULTZ, Fran SHANAHAN, Derek WISWELL, Xiaoying XU, Quiao ZHOU, Ray JAMES, Vidyadhar PARADKAR, Haengsoon PARK, Laura ROKOSZ, Tara STAUFFER and Timothy GUZI. Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2. Bioorganic & Medicinal Chemistry Letters. 2007, vol. 2007, No 17, p. 6220-6223. ISSN 0960-894X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2
Name in Czech Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2
Authors PARUCH, Kamil (203 Czech Republic, guarantor), Michael DWYER (840 United States of America), Carmen ALVAREZ (840 United States of America), Courtney BROWN (840 United States of America), Tin-Yau CHAN (840 United States of America), Ronald DOLL (840 United States of America), Kerry KEERTIKAR (840 United States of America), Chad KNUTSON (840 United States of America), Brian MCKITTRICK (840 United States of America), Jocelyn RIVERA (840 United States of America), Randall ROSSMAN (840 United States of America), Greg TUCKER (840 United States of America), Thierry FISCHMANN (840 United States of America), Alan HRUZA (840 United States of America), Vincent MADISON (840 United States of America), Amin NOMEIR (840 United States of America), Yaolin WANG (840 United States of America), Emma LEES (840 United States of America), David PARRY (840 United States of America), Nicole SGAMBELLONE (840 United States of America), Wolfgang SEGHEZZI (840 United States of America), Lesley SCHULTZ (840 United States of America), Fran SHANAHAN (840 United States of America), Derek WISWELL (840 United States of America), Xiaoying XU (840 United States of America), Quiao ZHOU (840 United States of America), Ray JAMES (840 United States of America), Vidyadhar PARADKAR (840 United States of America), Haengsoon PARK (840 United States of America), Laura ROKOSZ (840 United States of America), Tara STAUFFER (840 United States of America) and Timothy GUZI (840 United States of America).
Edition Bioorganic & Medicinal Chemistry Letters, 2007, 0960-894X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL URL URL
Impact factor Impact factor: 2.604
RIV identification code RIV/00216224:14310/07:00035878
Organization unit Faculty of Science
UT WoS 000250906200036
Keywords (in Czech) CDK2 kináza; inhibitor; rakovina
Keywords in English CDK2 kinase; inibitor; cancer
Tags cancer, CDK2 kinase, inibitor
Tags Reviewed
Changed by Changed by: doc. Mgr. Kamil Paruch, Ph.D., učo 108413. Changed: 21/7/2009 13:39.
Abstract
Properly substituted pyrazolo[1,5-a]pyrimidines are potent and selective CDK2 inhibitors. Compound 15j is orally available and showed efficacy in a mouse A2780 xenograft model.
Abstract (in Czech)
viz anotace
PrintDisplayed: 30/7/2024 21:26